Percutaneous transluminal coronary angioplasty, alone or in combination with urokinase therapy, during acute myocardial infarction

Japanese Circulation Journal

Volumn 63, Issue 2, 1999, Pages 91-96

  Oshima, Shuichi ^a   Saito, Taro ^a   Nakamura, Shota ^a   Noda, Katsuo ^a   Date, Haruhiko ^a   Hokimoto, Seiji ^a   Taniguchi, Izumi ^a   Yamamoto, Nobuyasu ^a  

^a Kumamoto Central Hospital   (Japan)

Author keywords

Acute myocardial infarction; Acute restenosis; Direct PTCA; Intracoronary thrombolysis

Indexed keywords

HEPARIN; UROKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY DISEASE; EMERGENCIES; FIBRINOLYTIC AGENTS; HEART CATHETERIZATION; HEART RUPTURE; HEMORRHAGE; HUMANS; INCIDENCE; MYOCARDIAL INFARCTION; RECURRENCE; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR; VENTRICULAR FIBRILLATION;

EID: 0033039609     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.91     Document Type: Article

References (32)

1. Robert WC, Jones AA: Quantification of coronary arterial narrowing at necropsy in acute transmural myocardial infarction: analysis and comparison of findings in 27 patients and 22 controls. Circulation 1980; 61: 786-790
2. De Wood MA, Spores J, Notske R, Mouser LT, Burroughts R, Golden MS, et al: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902
3. Rentrop P, Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K: Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981; 63: 307-317
4. Mizuno K, Satomura H, Miyamoto A, Arakawa K, Shibuya T, Arai T, et al: Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992; 326: 287-291
5. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al: Thrombolysis in myocardial infarction (TIMI) trial, phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 1987; 76: 142-154
6. Gruppo Italiano per lo Studio della Streptochi-nase nell' Infarto Miocardico (GISSI): Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987; 2: 871-874
7. White HD, Rivers JT, Maslowski AH, Ormiston JA, Takayama M, Hart HH, et al: Effect of intravenous streplokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. N Engl J Med 1989; 320: 817-821
8. The GUSTO Investigators: An international trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682
9. Collen D, Topol EJ, Tiefenbrunn AJ, Gold HK, Weisfeldt ML, Sobel BE, et al: Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Circulation 1984; 70: 1012-1017
10. Williams DO, Borer J, Braunwald E, Chesebro JH, Cohen LS, Dalen J, et al: Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. Circulation 1986; 73: 338-346
11. Gold HK, Leinbach RC, Garabedian HD, Yasuda T, Johns JA, Grossbard EB, et al: Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation 1986; 73: 347-352
12. Ohman EM, Califf RM, Topol EJ, Candela R, Abbottsmith C, Ellis S, et al. the TAMI Study Group: Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990; 82: 781-791
13. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, et al: A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987; 317: 581-588
14. Harrison DG, Ferguson DW, Collins SM, Skorton DJ, Ericksen EE, Kioschos JM, et al: Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesion. Circulation 1984; 69: 991-999
15. Ellis SG, Topol EJ, George BS, Kereiakes DJ, Debowey D, Sigmon KN, et al: Recurrent ischemia without warning: analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation 1989; 80: 1159-1165
16. Grines CL, Browne KF, Marko J, Rothbaum D, Stone GW, O'Keefe J, et al: for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-679
17. Zijlstra F, Bore MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H: A comparison of coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-684
18. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ, for the Mayo Coronary Care Unit and Catheterization Laboratory Groups: Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-691
19. Stack RS, O'Connor CM, Mark DB, Mark DB, Hinohara T, Phillips HR, et al: Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase. Circulation 1988; 77: 151-161
20. Sherman CT, Litvack F, Grundfest W, Lee M, Hickey A, Chaux A, et al: Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 1986; 315: 913-919
21. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American Heart Association/ American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993; 88: 2987-3007
22. The TIMI Study Group: The thrombolysis in myocardial infarction (TIMI) trial: phase 1 findings. N Engl J Med 1985; 312: 932-936
23. Salinger MH, Lopez A, Frohlich TG, McDonough TJ, Muester DC, Stagl RD: Systemic and local saphenous vein graft thrombolysis using a tissue plasminogen activator. Cathet Cardiovasc Diagn 1990; 19: 198-201
24. Chapekis AT, George BS, Candela RJ: Rapid thrombus dissolution by continuous infusion of urokinase through an intracornary perfusion wire prior to and following PTCA: results in native coronaries and saphenous vein grafts. Cathet Cardiovasc Diagn 1991; 23: 89-92
25. The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-961
26. Walter BF, Rothbaum DA, Pinkerton CA, Cowley MJ, Linnemeier JJ, Orr C, et al: Status of the myocardium and infarct related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptkinase r-tissue plasminogen activator) mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. J Am Coll Cardiol 1987; 9: 785-801
27. Eisenberg PR, Snerman LA, Jaffe AS: Paradoxical elevation of fibrinopeptide A after streptkinase: evicence for continued thrombosis despite intense fibrinolysis. J Am Coll Cardiol 1987; 10: 527-535
28. Ambrose JA, Almeida OD, Sharma SK, Torre SR, Marnur JD, Israel DH, et al: for the TAUSA Investigators. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: Results of the TAUSA trial. Circulation 1994; 90: 69-77
29. Kanamasa K, Ishida N, Kato H, Sakamoto S, Nakabayashi T, Otani N, et al: Recombinant tissue plasminogen activator prevents intimai hyperplasia after balloon angioplasty in hypercholesterolemic rabbits. Jpn Circ J 1996; 60: 889-894
30. Ogata Y, Taro S, Shibata T, Tsuruta K, Kashiwagi T, Fukushima Y, et al: Direct percutaneous transluminal coronary angioplasty combined with intravenous administration of recombinant tissue-type plasminogen activator in acute myocardial infarction. Kiso to Rinsyou 1989; 23: 537-549
31. Mahdi NA, Lopez J, Leon M, Pathan A, Harrell L, Jang IK, et al: Comparison of primary coronary stenting to primary balloon angioplasty with stent bailout for the treatment of patients with acute myocardial infarction. Am J Cardiol 1998; 81: 957-963
32. Stone GW, Brodie BR, Griffin JJ, Morice MC, Costantini C, Goar FGS, et al: for the Primary Angioplasty In Myocardial Infarction (PAMI) Stent Pilot Trial Investigators. Prospective, multicenter study of the safety and feasibility of primary slenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. J Am Coll Cardiol 1998; 31: 23-30